Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Alderson

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Archives of Biochemistry and Biophysics|April 21, 2006
S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediateNathan L Alderson, Yuping Wang, Matthew Blatnik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapyKory L Alderson, Qing Zhou, Vanessa Berner, et al.
BMC Health Services Research|October 9, 2024
Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trialCatherine Powell, Hanif Ismail, Liz Breen, et al.
JMIR Research Protocols|September 8, 2019
Exploring Severe Mental Illness and Diabetes: Protocol for a Longitudinal, Observational, and Qualitative Mixed Methods StudySue Bellass, Johanna Taylor, Lu Han, et al.
Diabetes|August 28, 2002
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetesAlan Stitt, Thomas A Gardiner, Nathan L Alderson, et al.
Diabetologia|July 10, 2004
Simple non-invasive assessment of advanced glycation endproduct accumulationR Meerwaldt, R Graaff, P H N Oomen, et al.
Physiological Genomics|December 18, 2003
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate agingHolly Van Remmen, Yuji Ikeno, Michelle Hamilton, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2013
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survivalRichard K Yang, Nicholas A Kalogriopoulos, Alexander L Rakhmilevich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2012
Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retentionRichard K Yang, Nicholas A Kalogriopoulos, Alexander L Rakhmilevich, et al.
Journal of Medical Internet Research|May 12, 2023
Development of a Supported Self-management Intervention for People With Severe Mental Illness and Type 2 Diabetes: Theory and Evidence-Based Co-design ApproachClaire Carswell, Peter A Coventry, Jennifer V E Brown, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Archives of Biochemistry and Biophysics|April 21, 2006
S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediateNathan L Alderson, Yuping Wang, Matthew Blatnik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapyKory L Alderson, Qing Zhou, Vanessa Berner, et al.
BMC Health Services Research|October 9, 2024
Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trialCatherine Powell, Hanif Ismail, Liz Breen, et al.
JMIR Research Protocols|September 8, 2019
Exploring Severe Mental Illness and Diabetes: Protocol for a Longitudinal, Observational, and Qualitative Mixed Methods StudySue Bellass, Johanna Taylor, Lu Han, et al.
Diabetes|August 28, 2002
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetesAlan Stitt, Thomas A Gardiner, Nathan L Alderson, et al.
Diabetologia|July 10, 2004
Simple non-invasive assessment of advanced glycation endproduct accumulationR Meerwaldt, R Graaff, P H N Oomen, et al.
Physiological Genomics|December 18, 2003
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate agingHolly Van Remmen, Yuji Ikeno, Michelle Hamilton, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2013
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survivalRichard K Yang, Nicholas A Kalogriopoulos, Alexander L Rakhmilevich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2012
Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retentionRichard K Yang, Nicholas A Kalogriopoulos, Alexander L Rakhmilevich, et al.
Journal of Medical Internet Research|May 12, 2023
Development of a Supported Self-management Intervention for People With Severe Mental Illness and Type 2 Diabetes: Theory and Evidence-Based Co-design ApproachClaire Carswell, Peter A Coventry, Jennifer V E Brown, et al.
Pageof 15